Risk Minimisation Material: Sprayvato (Esketamine) Nasal Spray – Healthcare Professional Guide
This guide informs healthcare professionals about identified risks that may occur following treatment: transient dissociative states, sedation, increased blood pressure and drug abuse. It explains how to minimise and manage these risks.
Source:
electronic Medicines compendium
SPS commentary:
A “Readiness to Leave” checklist (to ensure patients are safe to be discharged following administration), and a patient guide have been produced in conjunction.